Chemotherapy infusion pumps market seen hitting $6.95 billion by 2030

The Business Research Company says the chemotherapy infusion pumps market will grow from $5.2 billion in 2025 to $6.95 billion by 2030, driven by rising cancer cases and more outpatient and home-based treatment. The report highlights North America as the largest market in 2025 and Asia-Pacific as the fastest-growing region.

Why it matters: - Chemotherapy infusion pumps support more precise drug delivery for cancer treatment, which can improve outcomes and reduce side effects. - The market growth points to rising demand for infusion-based oncology care in hospitals, outpatient settings and at home. - The report’s forecast reflects broader pressure on health systems as cancer incidence continues to climb.

What happened: - The Business Research Company released a 2026 market report on the global chemotherapy infusion pumps market. - The market is projected to rise from $5.2 billion in 2025 to $5.51 billion in 2026. - The report forecasts the market will reach $6.95 billion by 2030. - The projected compound annual growth rate is 6.0% from 2025 to 2030.

The details: - Chemotherapy infusion pumps are specialized medical devices that deliver exact, continuous doses of chemotherapy drugs. - The devices are used in hospitals and in patients’ homes. - Historical growth has been tied to rising global cancer incidence, heavier reliance on chemotherapy, more oncology-focused healthcare centers, broader acceptance of infusion-based drug delivery and improved pump safety standards. - The forecast is supported by a shift toward outpatient cancer treatment, stronger demand for home-based oncology care, efforts to shorten hospital stays, wider use of personalized chemotherapy and better access to cancer therapies in emerging markets. - The report identifies rising use of ambulatory and home infusion delivery, more precise drug administration, disposable pump systems, continuous infusion regimens and patient comfort as key trends. - In 2025, North America held the largest share of the market. - Asia-Pacific is expected to be the fastest-growing region during the forecast period. - The regional analysis also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - The report’s new 2026 additions include market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technology analysis and updated graphics and tables. - The company offered a free sample and the full report through sample report and full market report.

Between the lines: - The strongest demand drivers are shifting from inpatient cancer care toward outpatient and home settings. - The emphasis on precision, portability and disposable systems suggests buyers want easier workflows and better patient adherence. - The World Health Organization projected in February 2024 that new cancer cases will top 35 million by 2050, a 77% increase from 20 million in 2022.

What's next: - The chemotherapy infusion pumps market is expected to keep expanding as outpatient oncology care and home treatment become more common. - The report points to continued adoption of personalized chemotherapy protocols and continuous infusion regimens. - Growth in emerging markets could widen access to cancer therapies and support additional demand for infusion devices.

The bottom line: - Rising cancer burden and a shift to less hospital-intensive care are keeping chemotherapy infusion pumps on a steady growth path.